Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

601
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
601

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodies.

JCI insight·2026
Same author

Pathogen-specific host responses define distinct pneumonia endotypes in the human lung.

bioRxiv : the preprint server for biology·2026
Same author

Bayesian Dosing Simulator (BDS): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy.

Pharmacotherapy·2026
Same author

Development of a Pilot Machine Learning Model to Predict Successful Short-Term Treatment Success in Critically Ill Patients With Community-Acquired Pneumonia.

CHEST critical care·2026
Same author

Comparing Clinical Assessments of Pneumonia to Bronchoalveolar Lavage Results in Critically Ill Patients With Suspected Pneumonia.

Annals of the American Thoracic Society·2026
Same author

Evaluating the Association Between Patient Priorities and ICU Care Delivery in Adults Receiving Mechanical Ventilation.

Chest·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.0K

Surrogate markers and microbiologic end points.

Richard G Wunderink1

  • 1Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA. wunderink@northwestern.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|July 6, 2010
PubMed
Summary
This summary is machine-generated.

Microbiologic eradication is difficult for pneumonia treatment studies. Biomarkers like procalcitonin show promise for assessing bacterial eradication in VAP patients.

More Related Videos

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.3K
Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
11:09

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres

Published on: October 23, 2011

16.7K

Related Experiment Videos

Last Updated: Jan 19, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.0K
A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.3K
Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
11:09

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres

Published on: October 23, 2011

16.7K

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Critical Care Medicine

Background:

  • Microbiologic eradication is the ideal primary endpoint for infectious disease treatment studies, including pneumonia.
  • Ventilational-associated pneumonia (VAP) presents unique challenges that preclude using microbiologic eradication as a primary endpoint.
  • Difficulties include lack of baseline positive cultures, distinguishing colonization from infection, unavailability of specimens for cure determination, and antibiotic-induced colonization.

Purpose of the Study:

  • To evaluate the suitability of microbiologic eradication as a primary endpoint in pneumonia and VAP treatment studies.
  • To explore alternative methods like serial quantitative cultures and biomarkers for assessing microbiologic outcomes in VAP.
  • To determine the role of procalcitonin levels in evaluating bacterial eradication in VAP.

Main Methods:

  • Review of challenges associated with using microbiologic eradication as a primary endpoint in pneumonia and VAP.
  • Exploration of serial quantitative cultures as a potential method for determining microbiologic failure.
  • Analysis of procalcitonin levels as a biomarker for bacterial eradication in VAP treatment.

Main Results:

  • Microbiologic eradication faces significant challenges in pneumonia and VAP, making it unsuitable as a primary endpoint.
  • Serial quantitative cultures show promise, particularly for multidrug-resistant pathogens in open-label studies, but require further research.
  • Procalcitonin levels, while not a primary endpoint alone, can be a valuable adjunct to clinical evaluation, with decreasing levels correlating with bacterial eradication.

Conclusions:

  • Standard microbiologic eradication is not a feasible primary endpoint for VAP treatment studies due to inherent difficulties.
  • Serial quantitative cultures and biomarkers like procalcitonin offer potential alternative or adjunct methods for assessing treatment efficacy.
  • Further research is necessary to validate these alternative methods for routine clinical use in VAP management.